Boosters for all adults, conflicting advice

WHO advice on boosters, Link to free download my 2 textbooks

http://159.69.48.3/

https://www.youtube.com/watch?v=uGCK8Z27xd0

No country can simply vaccinate its way out of the pandemic

Its not vaccine ‘or’

Its vaccines ‘and’

It makes no sense to give boosters to healthy adults

(when high risk around the world are still wating for their first dose)

Every day there are 6 times more booster doses administered than primary doses in poorer countries

This is a scandal that must stop now

Food and Drug Administration

https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-expands-eligibility-covid-19-vaccine-boosters

https://www.cdc.gov/vaccines/acip/index.html

Amended the emergency use authorizations (EUA) for Moderna and Pfizer

Moderna (half of the primary dose)

A single booster dose for all 18 and older

Acting FDA Commissioner Janet Woodcock

helps to provide continued protection against COVID-19,

including the serious consequences that can occur,

such as hospitalization and death

At least six months after primary vaccination series

At least two months after Janssen

Data Supporting Effectiveness

Moderna, FDA analysis

Study group

N= 149 from the original clinical studies who received a booster

Controls group

N = 1,055 two-dose series

Result

The antibody response against the SARS-CoV-2 virus 29 days after a booster dose of the vaccine demonstrated a booster response.

Pfizer-BioNTech

Study group

N= 200 who received a booster

Controls group

Same people, one month after the two-dose primary series

Result

The antibody response demonstrated a booster response.

FDA Evaluation of Benefits and Risks

Additional real-world data,

on the recently increasing number of cases of COVID-19 in the U.S.

and on the risk of myocarditis and pericarditis following vaccination

The FDA has determined that the benefits of a single booster dose of either the Moderna or Pfizer-BioNTech COVID-19 vaccines

outweigh the risks of myocarditis and pericarditis

in individuals age 18 years of age and older

Both Pfizer and Moderna are conducting post-authorization/post-marketing studies

to assess known serious risks of myocarditis and pericarditis.